Overview

Wernicke's encephalopathy is an acute, life-threatening neurological disorder caused by a deficiency of thiamine (vitamin B1). It is most commonly associated with chronic alcohol use disorder, but it can also arise from any condition that leads to severe malnutrition, prolonged vomiting, malabsorption, or increased metabolic demand. Prompt recognition and treatment are critical because the condition can progress to irreversible neurological damage, including Korsakoff syndrome, a chronic disorder of memory and confabulation.

Pathophysiology

Thiamine is an essential cofactor for several enzymes involved in glucose metabolism, including transketolase, pyruvate dehydrogenase, and alpha-ketoglutarate dehydrogenase. When thiamine is deficient, cerebral energy metabolism is impaired, leading to cellular damage in regions with high metabolic demand. Characteristic lesions appear symmetrically in the periventricular gray matter, particularly the medial thalamus, mammillary bodies, periaqueductal gray matter, and the oculomotor nuclei.

Clinical Features

The classic triad of Wernicke's encephalopathy consists of ophthalmoplegia, ataxia, and confusion. However, the complete triad is present in only a minority of cases, so a high index of suspicion is required, especially in at-risk patients.

• Ophthalmoplegia and nystagmus: Patients frequently exhibit horizontal nystagmus, and sometimes vertical nystagmus, along with weakness of the lateral rectus muscles (abducens nerve palsy). Conjugate gaze palsies can also occur.
• Ataxia: Gait ataxia is common and ranges from mild unsteadiness to an inability to stand. The ataxia primarily reflects cerebellar and vestibular involvement.
• Confusion and altered mental status: Patients may present with apathy, drowsiness, disorientation, inattention, or a global confusional state. In severe cases, coma or stupor can develop.

Other possible findings include hypotension, hypothermia, peripheral neuropathy, and signs of autonomic dysfunction. Without treatment, the condition can progress to Korsakoff syndrome, characterized by profound anterograde amnesia and impaired recent memory.

Diagnosis

Wernicke's encephalopathy is primarily a clinical diagnosis. Diagnostic criteria have been proposed, requiring two of the following four signs: dietary deficiency, oculomotor abnormalities, cerebellar dysfunction, and altered mental status. In practice, treatment is often initiated empirically when the condition is suspected, because the risks of untreated disease outweigh the risks of treatment.

Magnetic resonance imaging can support the diagnosis by demonstrating symmetric hyperintensities in the mammillary bodies, medial thalami, periaqueductal region, and tectal plate on T2-weighted or fluid-attenuated inversion recovery sequences. Blood thiamine levels are not routinely available in real time, and serum levels do not always reflect tissue stores, so clinicians should not delay treatment while awaiting laboratory confirmation.

Treatment

Wernicke's encephalopathy is a medical emergency that requires immediate parenteral thiamine administration. Intravenous thiamine should be given promptly at high doses, as oral replacement is insufficient to correct cerebral deficiency rapidly. Magnesium, an important cofactor for thiamine-dependent enzymes, should also be replenished if deficient. Patients should be monitored for clinical response, with improvements in ophthalmoplegia and nystagmus often occurring within hours to days, while ataxia and confusion may resolve more slowly.

Before giving glucose to any malnourished or suspected thiamine-deficient patient, thiamine should be administered first, because glucose metabolism consumes thiamine stores and can precipitate or worsen Wernicke's encephalopathy.

Prevention and Prognosis

Preventive measures include thiamine supplementation in individuals at risk, particularly those with alcohol use disorder, persistent vomiting, or malabsorptive conditions. With timely and adequate treatment, many patients show significant improvement. However, residual nystagmus, ataxia, or memory deficits can persist, and a substantial proportion of patients develop Korsakoff syndrome with permanent cognitive disability. Early recognition remains the single most important factor in improving outcomes.